Jobs filters
POSTDOCTORAL FELLOW - CANCER IMMUNOTHERAPIES - 10034053
Duarte, CAPOSTDOCTORAL FELLOW - 10034052
Duarte, CARESEARCH ASSOCIATE I - 10034172
Duarte, CAPATIENT ACCESS REPRESENTATIVE III - OC - 10033437
Irvine, CAPOSTDOCTORAL FELLOW - HEMATOLOGICAL MALIGNANCIES TRANSLATIONAL SCIENCE - 10034028
Monrovia, CAPHYSICIAN SCIENTIST | DIABETES, ENDOCRINOLOGY & METABOLISM | DUARTE, CA - 10034303
Duarte, CAMANAGER, PATIENT AND FAMILY RESOURCE CENTER - 10034328
Duarte, CACHIEF QUALITY OFFICER- SYSTEM - 10034326
Duarte, CAPHLEBOTOMIST LTA II - SPECIMEN PROCESSING - 10034291
Irvine, CADIRECTOR, BIOBANK LABORATORY OPERATIONS - 10033852
Duarte, CADOSIMETRIST I - 10034312
Duarte, CAPHYSICIAN| NUCLEAR MEDICINE RADIOLOGIST | DUARTE, CA - 10034159
Duarte, CA
POSTDOCTORAL FELLOW - HEMATOLOGICAL MALIGNANCIES TRANSLATIONAL SCIENCE - 10034028
Monrovia, CACity of Hope is an independent biomedical research and treatment center for cancer, diabetes and other life-threatening diseases.
Founded in 1913, City of Hope is a leader in bone marrow transplantation and immunotherapy such as CAR T cell therapy. City of Hope’s translational research and personalized treatment protocols advance care throughout the world. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a wholly owned subsidiary, was launched in 2019 and is dedicated to serving employers and their health care partners by providing access to City of Hope’s exceptional cancer expertise.
A National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network, City of Hope is ranked among the nation’s “Best Hospitals” in cancer by U.S. News & World Report and received Magnet Recognition from the American Nurses Credentialing Center. Its main campus is located near Los Angeles, with additional locations throughout Southern California and in Arizona.
Join the forefront of groundbreaking research at the Beckman Research Institute of City of Hope, where we're changing lives and making a real difference in the fight against cancer, diabetes, and other life-threatening illnesses. Our dedicated and compassionate faculty and staff are driven by a common mission: Contribute to innovative approaches in predicting, preventing, and curing diseases, shaping the future of medicine through cutting-edge research.
A Postdoctoral Fellowship opportunity is immediately available for the highly motivated individual in the laboratory of Ling Li, Ph.D., in the Department of Hematological Malignancies Translational Science, Department of Pediatrics, and Gehr Family Center for Leukemia Research.
You will directly work on the following projects:
1) Development of induced pluripotent stem cell-based human disease models
2) Understanding the role of immunity during tumorigenesis as well as disease relapses in order to design novel inhibitors, CAR-T cell therapy and antibody-based approach to intervene the malignancies
3) Identification of novel therapeutic target using high-throughput CRISPR genetic screen (e.g., metabolic pathway, mitochondria structure) in immune cells
The Li group conducts the most forefront science and is highly productive with publications in high-impact journals in the past five years, Nature Cancer (2024, 2026), Blood (2022, 2019, 2019), Blood Cancer Journal (2022), Cell Stem Cell (2018). The Li research program is supported by multiple NIH (R01s), American Cancer Society, The Alex’s Lemonade Stand Foundation and several other prestigious private awards.
As a successful candidate you will:
· Conduct the research project independently in one of listed research areas
· Supervise research intern in the lab
· Write the research papers, protocols and organize data for grant application
· Excellent communication skills, as the basis of internal or external collaboration
Your qualifications should include:
· PhD or M.D. with a strong background and profound knowledge in the field of either molecular biology, immunology, cancer biology, experience in sequencing or protein structural data analysis is highly preferred. Background with pharmacology, cell therapy or antibody engineering is also desired.
· Strong experience in induced pluripotent stem cell (iPSC) establishment possesses a deep understanding of the entire reprogramming process, from the sourcing of somatic cells to the final characterization and banking of high-quality, pluripotent lines. This expertise involves mastering numerous technical challenges, staying current with diverse reprogramming methods, and implementing rigorous quality control throughout the workflow.
· Literature knowledge of one of the research areas mentioned above.
· Evidence of scientific rigor and excellence as documented by peer-reviewed publications, strong trouble shooting skills
· Strong team player with excellent communication skills and fluency in English, both spoken and written.
City of Hope is an equal opportunity employer.
To learn more about our Comprehensive Benefits, please CLICK HERE.